Literature DB >> 9125561

Elongated versions of Vlp surface lipoproteins protect Mycoplasma hyorhinis escape variants from growth-inhibiting host antibodies.

C Citti1, M F Kim, K S Wise.   

Abstract

Variation in Vlp surface proteins of Mycoplasma hyorhinis was evaluated in terms of its role in determining susceptibility of organisms to growth inhibition by host antibodies (Abs). High-frequency switching of Vlp surface lipoproteins has been studied in isogenic lineages of M. hyorhinis SK76. In these lineages, the products of three genes, vlpA, vlpB, and vlpC, are subject to phase and size variation in vitro, which occur through distinct mutator elements that independently govern the expression of each vlp gene (promoter mutations) or the size of the vlp gene product (by intragenic expansion or contraction of a 3' region containing tandem repeats). Isogenic clonal variants of M. hyorhinis SK76 expressing distinct profiles of Vlp products were assessed for their susceptibility to complement-independent growth inhibition by serum Abs of swine experimentally infected with the arthritigenic SK76 strain. Invariably, variants expressing longer versions of VlpA, VlpB, or VlpC (each expressed individually) were completely resistant to host immune serum Abs, whereas variants expressing shorter allelic versions of each Vlp were susceptible. The target of growth-inhibiting Abs was not the Vlp products, since removal of anti-Vlp Abs had no effect on the inhibitory activity of the host immune serum on susceptible variants. Escape variant populations derived by propagating susceptible variants in an immune (versus control) host serum revealed a strong selection for the long-Vlp phenotype, irrespective of the identity of the Vlp expressed. Apparent mutational pathways of acquiring the protective phenotype included mutational switches to express long vlp genes that had been transcriptionally silent or switches to elongate expressed vlp genes. These results suggest that a major function of the Vlp system is to shield the wall-less mycoplasma surface from host Abs capable of binding vital (and as-yet-unidentified) surface antigens of this organism.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9125561      PMCID: PMC175216          DOI: 10.1128/iai.65.5.1773-1785.1997

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  46 in total

Review 1.  The directed mutation controversy and neo-Darwinism.

Authors:  R E Lenski; J E Mittler
Journal:  Science       Date:  1993-01-08       Impact factor: 47.728

2.  Complete sequence analysis of the genome of the bacterium Mycoplasma pneumoniae.

Authors:  R Himmelreich; H Hilbert; H Plagens; E Pirkl; B C Li; R Herrmann
Journal:  Nucleic Acids Res       Date:  1996-11-15       Impact factor: 16.971

3.  Modifications of the growth inhibition test and its application to human T-mycoplasmas.

Authors:  F T Black
Journal:  Appl Microbiol       Date:  1973-04

4.  Identification of mycoplasma membrane proteins by systematic Tn phoA mutagenesis of a recombinant library.

Authors:  C M Cleavinger; M F Kim; J H Im; K S Wise
Journal:  Mol Microbiol       Date:  1995-10       Impact factor: 3.501

5.  Borrelia burgdorferi antigens that are targeted by antibody-dependent, complement-mediated killing in the rhesus monkey.

Authors:  M K Aydintug; Y Gu; M T Philipp
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

6.  Interplay between mycoplasmas and host target cells.

Authors:  J B Baseman; M Lange; N L Criscimagna; J A Giron; C A Thomas
Journal:  Microb Pathog       Date:  1995-08       Impact factor: 3.738

7.  In vitro inhibition of Borrelia burgdorferi growth by antibodies.

Authors:  A Sadziene; P A Thompson; A G Barbour
Journal:  J Infect Dis       Date:  1993-01       Impact factor: 5.226

8.  Analysis of 0.5-kilobase-pair repeats in the Mycoplasma hominis lmp gene system and identification of gene products.

Authors:  S A Ladefoged; L T Jensen; B Brock; S Birkelund; G Christiansen
Journal:  J Bacteriol       Date:  1996-05       Impact factor: 3.490

9.  Antigenic topology of the P29 surface lipoprotein of Mycoplasma fermentans: differential display of epitopes results in high-frequency phase variation.

Authors:  P Theiss; A Karpas; K S Wise
Journal:  Infect Immun       Date:  1996-05       Impact factor: 3.441

10.  Antibody-resistant mutants of Borrelia burgdorferi: in vitro selection and characterization.

Authors:  A Sădziene; P A Rosa; P A Thompson; D M Hogan; A G Barbour
Journal:  J Exp Med       Date:  1992-09-01       Impact factor: 14.307

View more
  35 in total

1.  Gene rearrangements in the vsa locus of Mycoplasma pulmonis.

Authors:  X Shen; J Gumulak; H Yu; C T French; N Zou; K Dybvig
Journal:  J Bacteriol       Date:  2000-05       Impact factor: 3.490

2.  Gene families encoding phase- and size-variable surface lipoproteins of Mycoplasma hyorhinis.

Authors:  C Citti; R Watson-McKown; M Droesse; K S Wise
Journal:  J Bacteriol       Date:  2000-03       Impact factor: 3.490

3.  Coupled phase-variable expression and epitope masking of selective surface lipoproteins increase surface phenotypic diversity in Mycoplasma hominis.

Authors:  Q Zhang; K S Wise
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

4.  Juxtaposition of an active promoter to vsp genes via site-specific DNA inversions generates antigenic variation in Mycoplasma bovis.

Authors:  I Lysnyansky; Y Ron; D Yogev
Journal:  J Bacteriol       Date:  2001-10       Impact factor: 3.490

Review 5.  Phase and antigenic variation in bacteria.

Authors:  Marjan W van der Woude; Andreas J Bäumler
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

6.  Association of a major protein antigen of Mycoplasma arthritidis with virulence.

Authors:  A-H T Tu; B Clapper; T R Schoeb; A Elgavish; J Zhang; L Liu; H Yu; K Dybvig
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

7.  Occurrence, plasticity, and evolution of the vpma gene family, a genetic system devoted to high-frequency surface variation in Mycoplasma agalactiae.

Authors:  Laurent-Xavier Nouvel; Marc Marenda; Pascal Sirand-Pugnet; Eveline Sagné; Michelle Glew; Sophie Mangenot; Valérie Barbe; Aurélien Barré; Stéphane Claverol; Christine Citti
Journal:  J Bacteriol       Date:  2009-04-17       Impact factor: 3.490

8.  Localized frameshift mutation generates selective, high-frequency phase variation of a surface lipoprotein encoded by a mycoplasma ABC transporter operon.

Authors:  P Theiss; K S Wise
Journal:  J Bacteriol       Date:  1997-06       Impact factor: 3.490

Review 9.  Molecular biology and pathogenicity of mycoplasmas.

Authors:  S Razin; D Yogev; Y Naot
Journal:  Microbiol Mol Biol Rev       Date:  1998-12       Impact factor: 11.056

10.  The Vsa proteins modulate susceptibility of Mycoplasma pulmonis to complement killing, hemadsorption, and adherence to polystyrene.

Authors:  Warren L Simmons; Kevin Dybvig
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.